Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
about
Retinoblastoma: a three-year-study at a Brazilian medical school hospital.Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.Current update on retinoblastomaCurrent therapy and recent advances in the management of retinoblastoma.Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern CaliforniaHSV‑TK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK.
P2860
Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@ast
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@en
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@nl
type
label
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@ast
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@en
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@nl
prefLabel
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@ast
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@en
Chemoreduction for retinoblast ...... for recurrence in 457 tumors.
@nl
P2093
P2860
P1476
Chemoreduction for retinoblast ...... s for recurrence in 457 tumors
@en
P2093
Abdallah Shelil
Anna T Meadows
Arman Mashayekhi
Carol L Shields
Jacqueline Cater
Jerry A Shields
P2860
P304
35-44; discussion 44-5
P577
2004-01-01T00:00:00Z